View Older Stories

Jan 5, 2023 11:15PM Geron Corporation Announces Pricing of $198 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants

Jan 4, 2023 04:19PM Geron Corp (GERN) Announces $175M Proposed Public Offering of Common Stock

Jan 4, 2023 04:19PM Geron Corporation Announces Proposed Public Offering of Common Stock

Oct 13, 2022 10:28AM Companies with NDRs 10/13

Apr 6, 2022 04:30PM Geron to Present at the 21st Annual Needham Virtual Healthcare Conference

Apr 1, 2022 04:15PM Geron Corporation Announces the Closing of its Public Offering of Common Stock and Warrants

Mar 30, 2022 05:55AM Geron Corp (GERN) Prices 53.3M Share Offering at $1.05/sh

Mar 30, 2022 02:25AM Geron Corporation Announces the Pricing of its Public Offering of Common Stock and Warrants

Mar 29, 2022 04:01PM Geron Corp (GERN) Announces Proposed Stock and Warrant Offering, Size not Disclosed

Mar 29, 2022 04:01PM Geron Corporation Announces Proposed Public Offering of Common Stock and Warrants

Mar 11, 2022 06:05AM Needham & Company Reiterates Buy Rating on Geron Corporation (GERN)

Oct 26, 2021 09:28AM Pre-Open Stock Movers 10/26: (WBX) (BKKT) (OCGN) Higher; (VTNR) (CLAR) (BYND) Lower (more...)

May 27, 2020 04:30PM Geron Corporation Announces the Closing of its Public Offering of Common Stock and Warrants

May 22, 2020 07:15AM Geron Corp (GERN) Announces Pricing of its Public Offering of Common Stock and Warrants

May 22, 2020 07:15AM Geron Corporation Announces the Pricing of its Public Offering of Common Stock and Warrants

Apr 8, 2020 04:30PM Geron to Present at Needham Virtual Healthcare Conference

Apr 9, 2019 09:19AM Pre-Open Stock Movers 04/09: (PHAS) (CERN) (AVYA) Higher; (ZGNX) (ZSAN) (DARE) Lower (more...)

Apr 9, 2019 06:18AM Needham & Company Upgrades Geron Corporation (GERN) to Buy

Apr 2, 2019 04:30PM Geron to Present at Needham Healthcare Conference

Mar 27, 2018 09:01AM Pre-Open Movers 03/27: (ATRS) (PETX) (RHT) Higher; (LFIN) (GERN) (OSTK) Lower (more...)

Mar 21, 2018 07:30AM Geron to Present at the Needham Healthcare Conference

Mar 2, 2017 06:08AM Needham and Company Maintains Hold Rating on Geron Corp (GERN); Looks Ahead to 'Crucial Imetelstat Interim Analyses in 2Q'

Sep 12, 2016 03:08PM Notable 52-Week Highs and Lows 9/12: (APA) (SWFT) (NPTN) Higher; (GERN) (TSCO) Lower

Apr 5, 2016 07:30AM Geron to Present at the Needham Healthcare Conference

Apr 7, 2015 04:15PM Geron to Present at the 14th Annual Needham Healthcare Conference

Jun 12, 2014 09:30AM Pre-Open Stock Movers 6/12: (ZLCS) (GERN) (RH) Higher; (LULU) (ARIA) (APU) Lower (more...)

Mar 19, 2014 09:26AM Pre-Open Stock Movers 3/19: (HZNP) (PRTA) (KBH) Higher; (RENN) (RBCN) (KNDI) (ORCL) Lower (more...)

Mar 18, 2014 12:53PM Unusual 11 Mid-Day Movers 03/18: (GERN) (XGTI) (BGMD) Higher; (GGS) (KIOR) ETAK) Lower

Mar 12, 2014 12:56PM Needham & Company Downgrades Geron Corporation (GERN) to Hold

Dec 10, 2013 10:42AM Notable Analyst Rating Changes 12/10: (CELG) (GERN) (ARIA) Upgraded; (DGX) (HME) (CHL) Downgraded

Dec 10, 2013 09:24AM Pre-Open Stock Movers 12/10: (ARIA) (RMBS) (GERN) Higher; (GNK) (EGLE) (PBY) Lower (more...)

Dec 10, 2013 06:45AM Needham & Company Upgrades Geron Corporation (GERN) to Buy on Imetelstat Data

Dec 6, 2013 09:34AM Mayo Clinic Article on Geron (GERN) Doeesn't Offer a Lot New - Needham & Company

Jun 28, 2012 07:43AM Needham & Company Starts Geron Corporation (GERN) at Hold; Six Ongoing Studies, But Outcome Hard to Predict

Aug 1, 2011 08:05AM Needham & Company Maintains a 'Hold' on Geron Corporation (GERN); Awaiting Data from Novel Programs to Drive Valuation Thesis

Apr 21, 2011 08:09AM Needham & Company Maintains a 'Hold' on Geron Corporation (GERN); Comprehensive, Yet Early-Stage Cell Therapy Program Progresses; Await Potential Partnerships

Apr 12, 2011 07:39AM Needham & Company on Biotechnology & Life Sciences: Oncology / Hematology Review from the 2011 Needham Healthcare Conference

Mar 30, 2011 07:47AM Needham & Company Maintains a 'Hold' on Geron Corporation (GERN); Lunch and a Solid Plan for Geron’s Cancer Programs Were Served at the Investor/Analyst Meeting

Feb 28, 2011 08:01AM Needham & Company Maintains a 'Hold' on Geron (GERN); Several Novel Clinical Programs in Cancer and Stem Cells Expected to Advance in 2011, Yet We Await Data in Late 2011/Early 2012

Aug 2, 2010 08:18AM Geron (GERN) volatility at 67; shares rallied on FDA lifting hold on stem cell therapy

Nov 2, 2009 10:48AM Notable Analyst Rating Changes 11/02: MOT, UFS, GNW, EL, JWN, WY, RCL, CS Upgraded; RIMM, PALM, CMCSA, ERJ, GERN Downgraded

Nov 2, 2009 08:19AM Needham & Co Downgrades Geron Corporation (GERN) to Hold

Nov 2, 2009 07:50AM Needham Downgrades Geron (GERN) to Hold

Jun 30, 2009 11:05AM Needham & Co Comments On Geron (GERN) After GE Healthcare News

Jan 23, 2009 01:28PM One Biotech Watcher Is Not Buying Into The Geron (GERN) "Hype"

Jan 23, 2009 12:12PM Needham & Co Upgrades Geron Corporation (GERN) to Buy

View Older Stories